Prevalence of Post-COVID conditions among Mexican COVID-19 survivors: a nationwide cross-sectional study.
BMC Public Health
; 24(1): 1729, 2024 Jun 28.
Article
em En
| MEDLINE
| ID: mdl-38943168
ABSTRACT
BACKGROUND:
There are limited population-representative data that describe the potential burden of Post-COVID conditions (PCC) in Mexico. We estimated the prevalence of PCC overall and by sociodemographic characteristics among a representative sample of adults previously diagnosed with COVID-19 in Mexico. We additionally, characterized the PCC symptoms, and estimated the association between diagnosed type-2 diabetes and hypertension with PCC.METHODS:
We used data from the 2021 National Health and Nutrition Survey in Mexico, a nationally and regionally representative survey, from August 1st to October 31st, 2021. Using the WHO definition, we estimated the prevalence of PCC by sociodemographics and prevalence of PCC symptoms. We fit multivariable log-binomial regression models to estimate the associations.RESULTS:
The prevalence of PCC was 37.0%. The most common persistent symptoms were fatigue (56.8%), myalgia or arthralgia (47.5%), respiratory distress and dyspnea (42.7%), headache (34.0%), and cough (25.7%). The prevalence was higher in older people, women, and individuals with low socioeconomic status. There was no significant association between hypertension and PCC or diabetes and PCC prevalence.CONCLUSIONS:
About one-third of the adult Mexican population who had COVID-19 in 2021 had Post-COVID conditions. Our population-based estimates can help assess potential priorities for PCC-related health services, which is critical in light of our weak health system and limited funding.Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sobreviventes
/
COVID-19
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article